Evelyne Bischof
Corporate Officer/Principal presso InSilico Medicine, Inc.
Profilo
Evelyne Bischof MD, MHP, FEFIM, is one of LongeVC's Advisory Board members and the Chairman of the Longevity Science Foundation Visionary Board.
She is also a longevity physician at Human Longevity, Inc., where she works with leading elite executives on their longevity, integrating precision diagnostics of HLI, AI-based monitoring with deep ageing analysis and individualised therapies.
Deeply passionate about next-generation medical technology, she is an expert in internal medicine and oncology, focusing on preventative and precision medicine, biogerontology and geronto-oncology.
Evelyne is enthusiastic about artificial intelligence applications for biomedical research and practice.
Apart from working at Human Longevity, Inc., she is also part of Holmusk, Insilico Medicine, Shanghai Jiao Tong University School of Medicine, and Shanghai University of Medicine and Health Sciences.
She also held positions at University Hospital Basel, Tongji University and University Hospital Zürich.
Evelyne spent a decade practicing medicine and performing translational research in Switzerland, the US and China.
A Harvard- and Columbia-trained physician, Evelyne is the author of more than 40 peer-reviewed papers and is a frequent speaker at scientific and medical conferences.
Posizioni attive di Evelyne Bischof
| Società | Posizione | Inizio |
|---|---|---|
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Corporate Officer/Principal | 01/12/2019 |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2020 |
LongeVC
 LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Consulente / Consigliere | - |
Precedenti posizioni note di Evelyne Bischof
| Società | Posizione | Fine |
|---|---|---|
Holmusk USA, Inc.
 Holmusk USA, Inc. Packaged SoftwareTechnology Services Holmusk USA, Inc. develops predictive algorithms that offer insights for personalized care and population health management. It focuses on solving problems in healthcare for chronic diseases. The firm's products include AptCare Suite, which is a digital health management platform built for community chronic care, and MindLinc, which integrates mental and behavioural health and practice management at all levels. The company was founded by Nawal Roy in 2015 and is headquartered in Singapore. | Corporate Officer/Principal | 30/04/2022 |
Formazione di Evelyne Bischof
| Harvard Medical School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Health Technology |
Holmusk USA, Inc.
Holmusk USA, Inc. Packaged SoftwareTechnology Services Holmusk USA, Inc. develops predictive algorithms that offer insights for personalized care and population health management. It focuses on solving problems in healthcare for chronic diseases. The firm's products include AptCare Suite, which is a digital health management platform built for community chronic care, and MindLinc, which integrates mental and behavioural health and practice management at all levels. The company was founded by Nawal Roy in 2015 and is headquartered in Singapore. | Technology Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Technology Services |
LongeVC
LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland. | Finance |
- Borsa valori
- Insiders
- Evelyne Bischof
